MedTrace Logo

Gait Analysis and Clinical Outcomes of Anterior and Lateral Approach Total Hip Arthroplasty.

NCT06538519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-08-05

No results posted yet for this study

Summary

The goal of this Prospective Randomized Study is to confirm presence or absence of differences in gait mechanics in direct anterior and lateral approaches for total hip arthroplasty. and to compare the clinical outcomes of both approaches.

The main questions it aims to answer are:

if the anterior approach to the hip is faster recovery than lateral approach? if the anterior approach to the hip has better gait mechanics than lateral approach?

Participants will:

undergo one of the two approaches for total hip arthroplasty. All patients will be followed up at 2 weeks, 6 weeks, 3 months and 18 months. gait analysis will be done at 6wks, 3m, and 18months.

Conditions

  • Hip Osteoarthritis

Interventions

PROCEDURE

total hip replacement using lateral approach

In the lateral approach partial detachment of the anterior one-third of the gluteus medius muscle.

PROCEDURE

total hip replacement using anterior approach

the anterior approach using an internervous plane between the tensor fascia latae and the sartorius muscle.

DEVICE

gait analysis at 6wks, 3 months and 18 months

gait analysis done in the gait lab at the mentioned postoperative periods

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-03
Primary Completion
2023-06-01
Completion
2023-07-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06538519 on ClinicalTrials.gov